Benzinga | Jan 10, 2022 07:44AM EST

Singular Genomics Partners With Lexogen To 'Enable RNA Library Prep for the G4 Sequencing Platform'

Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Lexogen to demonstrate the G4 sequencing platform's compatibility with Lexogen's products for RNA research, specifically the QuantSeq, CORALL and LUTHOR library preparation kits.



Transcriptome analysis has long been considered essential in answering key questions in biology and medicine. As pioneers in the field of RNA science, Lexogen has enabled RNA library preparation kits that are cost-efficient, streamlined and deliver complete transcript representation.

"We are pleased to partner with the RNA experts to make Lexogen's kits available to Singular Genomics customers. This collaboration underscores our commitment to providing a plug-and-play solution for our customers to seamlessly integrate the G4 into existing NGS workflows," said Jorge Velarde, Senior Vice President of Corporate Development and Strategy at Singular Genomics.

Torsten Reda, Chief Scientific Officer of Lexogen emphasized: "Our team is very excited to work together with Singular Genomics to extend the portfolio of G4 compatible RNA-seq library preparations to enable customers to use the G4 advantages such as speed and flexibility in parallelizing transcriptome analyzes."